In March 2025, the company declared new programs for any direct-to-purchaser supplying of its Wegovy weight loss drug. The company recognized a brand new pharmacy, termed NovoCare, which would charge consumers $499 every month for use of the drug, lower than fifty percent the price of the drug by way of other pharmaceutical distribution networks.[5